Translational Plastic Surgery: Handbook for Designing and Conducting Clinical and Translational Research | Chapter 14
Document Type
Book Chapter
Publication Date
1-30-2026
Editor
Adam E.M. Eltorai, Jeffrey A. Bakal, Jung Ho Gong, Loree Kalliainen, Paul Y. Liu
Abstract
The Food and Drug Administration (FDA) serves an important role in the United States as a key regulator of food, cosmetics, medications, medical products, and much more. They cite their mission is to protect the public health of the nation through regulation of products that have the potential to affect the health of the population. Many nations look to the FDA for guidance into how to better protect the health of their citizens, and the road to achieving this international authority was not without obstacles. This chapter discusses the history of the FDA and pivotal moments in time that forced government authorities to institute new regulatory practices that created the foundation that the FDA stands on today. This chapter will also delve into different products the FDA regulates, specifically those used in plastic and reconstructive surgery.
First Page
73
Last Page
76
Chapter Title
Chapter 14 - Other product types
Publisher
Academic Press
ISBN
[9780323998123, 9780323911689]
Rights
Copyright © 2026 Elsevier Inc.
Recommended Citation
Riklan, Joshua E.; Mardourian, Markos; Nichols, D. Spencer; Bryan, Jaime; Cox, Elizabeth; Oberhofer, Haley; and Chim, Harvey, "Translational Plastic Surgery: Handbook for Designing and Conducting Clinical and Translational Research | Chapter 14" (2026). School of Medicine Faculty Publications. 4485.
https://digitalscholar.lsuhsc.edu/som_facpubs/4485
10.1016/B978-0-323-91168-9.00063-6